Question explored with the scientific record
Conversation so far
- 1 Does pregabalin help with panic attacks?
- 2 Does it cause weight gain
- 3 What is best for panic attack for someone in methadone
Answered on this page ↓
What is best for panic attack for someone in methadone
The short version: the evidence does not directly answer what is best for panic attacks in someone on methadone. The retrieved studies cover SSRIs and pregabalin for panic disorder, but none test them in people taking methadone.
The retrieved evidence shows that SSRIs like paroxetine and fluoxetine reduce panic symptoms in general populations [2][3]. One review lists SSRIs, SNRIs, and pregabalin as treatments for panic disorder [5]. A one-year pregabalin study found it was tolerated and improved anxiety severity [4]. But every one of these studies was done in people not on opioid maintenance therapy.
Methadone changes how the body processes other drugs. It slows liver metabolism and affects the central nervous system in ways that can amplify sedation or change how an SSRI or pregabalin works. None of the retrieved studies accounted for this interaction. The closest record is a 2005 paper on pregnant women on methadone, which notes that 42 of 94 patients also used benzodiazepines [1]. That is a common combination, but it is not a safety or efficacy study of panic treatment.
| Treatment | Evidence for panic disorder | Tested in methadone patients? |
|---|---|---|
| SSRIs (paroxetine, fluoxetine) | Reduces panic symptoms in general populations [2][3] | No |
| Pregabalin | Improves anxiety severity over 1 year [4] | No |
| CBT + D-cycloserine | May speed improvement in severe cases [6] | No |
The evidence base for panic treatment in methadone patients is absent from this retrieval. That does not mean no such study exists, only that this search did not find it. What the retrieval does show is that the standard panic treatments have not been tested in this specific population.
My call: there is no evidence from these records to recommend one panic treatment over another for someone on methadone. Confidence: low.
Sources used 6
-
Prescription opioid dependence and treatment with methadone in pregnancy
Prescription opioid-dependent pregnant women in eastern Kentucky admitted for methadone maintenance therapy show predominant OxyContin use, extensive polysubstance abuse, and notable obstetric/maternal health challenges, with relatively low methadone stabilization doses and risi…
DOI: 10.5055/jom.2005.0022 -
Paroxetine: A Selective Serotonin Reuptake Inhibiting Antidepressant
Paroxetine is a selective serotonin reuptake inhibitor effective for moderate depression, with superior efficacy to placebo and comparable to tricyclic antidepressants, though limited long-term, elderly, and treatment-resistant data exist.
DOI: 10.1177/106002809302701012 -
Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability
This study investigates the effects of selective serotonin reuptake inhibitors (SSRIs) on learned helplessness in rats, demonstrating that their antidepressant-like effects are independent of serotonin availability and 5-HT 1A receptor function.
DOI: 10.1016/j.neuropharm.2006.10.014 -
Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability
This study evaluates the long-term safety and tolerability of pregabalin in patients with generalized anxiety disorder (GAD), social anxiety disorder (SAD), or panic disorder (PD) over a one-year open-label treatment period, finding it generally well tolerated with sustained imp…
DOI: 10.1185/03007995.2013.820694 -
Recent Developments in the Treatment of Panic Disorder (PD) and Generalized Anxiety Disorder (GAD)
This paper reviews recent developments in the pharmacological treatment of panic disorder (PD) and generalized anxiety disorder (GAD), comparing the efficacy and safety profiles of several drug classes including benzodiazepines, SSRIs, SNRIs, azapirones, pregabalin, antihistamin…
DOI: 10.1016/s0924-9338(10)70159-0 -
d-Cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial
In a randomized double-blind trial, adding 50 mg D-cycloserine to an 8-session in-clinic cognitive-behavioral therapy program with in-vivo exposures did not improve overall outcomes for panic disorder with agoraphobia, though it may hasten symptom reduction in more severely ill …
DOI: 10.1016/j.jpsychires.2011.01.020